Mechanistic Insights Into Long Covid: Viral Persistence, Immune Dysregulation, and Multi-Organ Dysfunction
- PMID: 40474772
- DOI: 10.1002/cph4.70019
Mechanistic Insights Into Long Covid: Viral Persistence, Immune Dysregulation, and Multi-Organ Dysfunction
Abstract
Long Covid is a post-viral syndrome characterized by persistent symptoms targeting multiple organ systems after initial SARS-CoV-2 infection. Current literature suggests that the mechanisms causing Long Covid involve viral persistence, immune dysregulation, systemic inflammation, endothelial dysfunction, and metabolic disturbances. By forming reservoirs in the tissues of various organs, SARS-CoV-2 may evade immunological clearances while triggering immune responses and contributing to chronic symptoms through cytokine imbalances, T-cell exhaustion, and systemic inflammation. These symptoms parallel other post-viral syndromes such as Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), suggesting similar mechanisms of pathology. The coronavirus has also been linked to neuroinflammation and endothelial dysfunction causing cognitive symptoms and cardiovascular complications. Furthermore, its ability to lower energy production links it to post-exertion malaise (PEM) and muscle pain. These symptoms may result from iron dysregulation and persistent oxidative stress due to Covid-impaired mitochondrial function. This review synthesizes current data on the mechanisms that drive Long Covid pathogenesis and explores potential therapeutic strategies to mitigate viral persistence, immune dysfunction, and metabolic disturbances. It is critical to understand these interactions to develop targeted interventions that address the long-term sequelae of SARS-CoV-2 infection and improve patient outcomes.
Keywords: COVID‐19; Long Covid; SARS‐CoV‐2; coronavirus; immune dysregulation; post‐acute sequelae of SARS‐CoV‐2 (PASC); viral persistence.
© 2025 American Physiological Society.
Similar articles
-
Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC).Elife. 2023 Mar 22;12:e86002. doi: 10.7554/eLife.86002. Elife. 2023. PMID: 36947108 Free PMC article. Review.
-
Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study.PLoS Med. 2025 Jan 23;22(1):e1004511. doi: 10.1371/journal.pmed.1004511. eCollection 2025 Jan. PLoS Med. 2025. PMID: 39847575 Free PMC article.
-
Cardiovascular and haematological pathology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A role for viruses.Blood Rev. 2023 Jul;60:101075. doi: 10.1016/j.blre.2023.101075. Epub 2023 Mar 20. Blood Rev. 2023. PMID: 36963989 Free PMC article. Review.
-
Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series.Brain Behav Immun Health. 2023 Dec 27;36:100720. doi: 10.1016/j.bbih.2023.100720. eCollection 2024 Mar. Brain Behav Immun Health. 2023. PMID: 38327880 Free PMC article.
-
Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.J Adv Res. 2022 Sep;40:179-196. doi: 10.1016/j.jare.2021.11.013. Epub 2021 Nov 26. J Adv Res. 2022. PMID: 36100326 Free PMC article. Review.
Cited by
-
Proteomic Profiling of Human Peripheral Blood Cell Targets of IgG Induced by SARS-CoV-2: Insights into Vaccine Safety.Vaccines (Basel). 2025 Jun 27;13(7):694. doi: 10.3390/vaccines13070694. Vaccines (Basel). 2025. PMID: 40733671 Free PMC article.
References
-
- AboTaleb, H. A., and B. S. Alghamdi. 2024. “Metformin and Fibromyalgia Pathophysiology: Current Insights and Promising Future Therapeutic Strategies.” Molecular Biology Reports 52, no. 1: 60. https://doi.org/10.1007/s11033‐024‐10159‐7.
-
- Achleitner, M., C. Steenblock, J. Dänhardt, et al. 2023. “Clinical Improvement of Long‐COVID Is Associated With Reduction in Autoantibodies, Lipids, and Inflammation Following Therapeutic Apheresis.” Molecular Psychiatry 28, no. 7: 2872–2877. https://doi.org/10.1038/s41380‐023‐02084‐1.
-
- Amani, B., and B. Amani. 2023. “Efficacy and Safety of Nirmatrelvir/Ritonavir (Paxlovid) for COVID‐19: A Rapid Review and Meta‐Analysis.” Journal of Medical Virology 95, no. 2: e28441. https://doi.org/10.1002/jmv.28441.
-
- Appelman, B., B. T. Charlton, R. P. Goulding, et al. 2024. “Muscle Abnormalities Worsen After Post‐Exertional Malaise in Long COVID.” Nature Communications 15, no. 1: 17. https://doi.org/10.1038/s41467‐023‐44432‐3.
-
- Baeza‐Flores, G. D. C., C. G. Guzmán‐Priego, L. I. Parra‐Flores, J. Murbartián, J. E. Torres‐López, and V. Granados‐Soto. 2020. “Metformin: A Prospective Alternative for the Treatment of Chronic Pain.” Frontiers in Pharmacology 11: 558474. https://doi.org/10.3389/fphar.2020.558474.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous